|
C4ORF14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.004000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.807600E-01 |
| Normal-vs-Stage2 |
6.240600E-01 |
| Normal-vs-Stage3 |
2.787600E-01 |
| Normal-vs-Stage4 |
7.531400E-01 |
| Stage1-vs-Stage2 |
7.659000E-01 |
| Stage1-vs-Stage3 |
2.863600E-01 |
| Stage1-vs-Stage4 |
9.356800E-01 |
| Stage2-vs-Stage3 |
6.489000E-01 |
| Stage2-vs-Stage4 |
8.553000E-01 |
| Stage3-vs-Stage4 |
4.863000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.537800E-01 |
| Normal-vs-AfricanAmerican |
7.094000E-01 |
| Normal-vs-Asian |
8.577400E-01 |
| Caucasian-vs-AfricanAmerican |
4.347800E-01 |
| Caucasian-vs-Asian |
7.305000E-01 |
| AfricanAmerican-vs-Asian |
6.365400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.156600E-01 |
| Normal-vs-Female |
5.086000E-01 |
| Male-vs-Female |
4.461800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.527000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.366600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.391800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.658200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.049400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.108400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.654400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.224000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.518800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.513600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.286800E-01 |
| Classical-VS-Follicular |
4.324200E-02 |
| Classical-VS-Other |
4.470400E-01 |
| Classical-VS-Normal |
9.638800E-01 |
| Tall-VS-Follicular |
3.890600E-01 |
| Tall-VS-Other |
3.693400E-01 |
| Tall-VS-Normal |
5.978000E-01 |
| Follicular-VS-Other |
9.714000E-02 |
| Follicular-VS-Normal |
1.190230E-01 |
| Other-VS-Normal |
4.481000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.736200E-01 |
| Normal-vs-N1 |
1.935000E-01 |
| N0-vs-N1 |
3.787200E-01 |
|
|
